Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kamud Drugs is a prominent Indian pharmaceutical company focused on the development and manufacture of Active Pharmaceutical Ingredients (APIs) and intermediates. Founded in 1989 and headquartered in Sangli, Maharashtra, the company specializes in anthelmintic, antifungal, and gastrointestinal therapeutic segments. Its core product offerings include high-demand APIs such as Albendazole, Fenbendazole, and Fluconazole, which are supplied to pharmaceutical formulators worldwide. Kamud Drugs maintains advanced manufacturing infrastructure that adheres to Good Manufacturing Practices (GMP), ensuring high-quality standards for both human and veterinary applications. The company plays a significant role in the global supply chain for essential generic medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kamud Drugs.